Antioxidant Ingredients Pomegranate Extract Ellagic Acid

Pomegranate extract ellagic acid is positioned within the cosmetic ingredients market as a "high-performance natural active ingredient". Its core value lies in its multi-targeted, multi-pathway skincare efficacy, perfectly aligning with contemporary consumers' pursuit of products that are "natural", "safe" and "highly effective". This positioning is primarily reflected in the following aspects:

• Pioneering Potent Antioxidant: Ellagic acid possesses exceptional antioxidant activity, with its oxygen radical absorbance capacity (ORAC value) indicating formidable free radical scavenging potential.
• Targeted Brightening Specialist: Ellagic acid is widely recognised as an effective tyrosinase inhibitor, disrupting melanin biosynthesis pathways at their source. In the Japanese market, it holds official approval as a quasi-drug ingredient for treating hyperpigmentation disorders like melasma, providing regulatory validation of its whitening efficacy.
• Comprehensive Anti-Ageing Guardian: Ellagic acid's anti-ageing effects extend beyond mere antioxidant activity. Research indicates it stimulates collagen synthesis while inhibiting the activity of matrix metalloproteinase-1 (MMP-1), the primary collagen-degrading enzyme. This protects the dermal matrix structure, delaying the appearance of photoageing signs like wrinkles and sagging.
• The Ingredient in Premium and Functional Formulations: Due to its high extraction and purification costs, high-purity ellagic acid is typically incorporated into serums, ampoules, and premium creams-high-performance products where it underpins core efficacy claims and premium positioning.

In summary, pomegranate extract ellagic acid occupies a pivotal niche within the cosmetic ingredient landscape as a "multi-functional natural active". It stands not only as a potent ingredient in antioxidant and brightening formulations but also as an ideal choice for brands developing premium, science-backed skincare products, offering clear positioning and broad market application prospects.

PS: This page focuses on the product application information.

For the product Technical Data Sheet, please click Pomegranate Extract Ellagic Acid HPLC98% 476-66-4.

For Integrated Supply Chain & Solutions, please click Pomegranate Extract Ellagic Acid Original Factory.

The core active ingredient, ellagic acid in pomegranate extract, derives its skincare efficacy from robust molecular biology and cellular physiology research. Its multi-pathway, multi-target mechanism enables fundamental intervention against skin oxidation, pigmentation, and ageing.

2.1 Potent Antioxidant and Free Radical Scavenging Mechanism

Ellagic acid's molecular structure is rich in phenolic hydroxyl groups. This structural feature endows it with exceptional electron-donating capacity, forming the chemical basis for its antioxidant activity. Its antioxidant mechanism primarily encompasses the following aspects:

• Direct Radical Scavenging: Ellagic acid stably donates electrons to neutralise highly reactive free radicals (e.g., hydroxyl radicals, superoxide anions, peroxy radicals), thereby deactivating their chain reaction potential and preventing oxidative stress damage to skin cell membrane lipids, proteins, and DNA.
• Activation of endogenous antioxidant defences: Ellagic acid upregulates the skin cells' own antioxidant enzyme systems. Research confirms it aids in restoring the activity of catalase, peroxidase, and superoxide dismutase. This effectively bolsters the skin cells' intrinsic 'firefighting' capabilities, providing sustained, dynamic antioxidant protection.
• Metal ion chelation: Ellagic acid's polyphenolic structure enables chelation of transition metal ions such as iron and copper. These ions act as key catalysts in the Fenton reaction, generating highly reactive hydroxyl radicals. Through chelation, ellagic acid indirectly suppresses the source of free radical formation, constituting a preventive antioxidant strategy.

2.2 Scientific Whitening and Pigment Regulation Mechanisms

Ellagic acid's whitening efficacy represents one of its most marketable attributes, with its mechanism primarily targeting critical stages of melanin synthesis:

• Competitive Inhibition of Tyrosinase Activity: Tyrosinase serves as the rate-limiting enzyme in melanin synthesis pathways, with its activity directly determining melanin yield. Ellagic acid shares structural similarity with tyrosine, the enzyme's substrate. It competitively binds to the enzyme's active site, thereby obstructing the oxidation of tyrosine and its intermediate product, dopa. This inhibits melanin formation at its source, constituting the most fundamental and direct whitening target.
• Intervention in Melanocyte Signalling: Factors such as ultraviolet radiation stimulate the secretion of α-melanocyte-stimulating hormone (α-MSH) through complex signalling pathways (e.g., the MAPK pathway), subsequently upregulating tyrosinase expression. Research suggests ellagic acid may interfere with these upstream signalling pathways, reducing UV-induced melanogenesis stimulation and thereby achieving a "preventive darkening" effect.
• Promoting Melanin Degradation and Metabolism: Some studies indicate that ellagic acid may accelerate the degradation of existing melanin granules or influence their transport rate to epidermal keratinocytes, facilitating the faster metabolism and elimination of formed pigments. This confers dual efficacy in both "reducing existing pigmentation" and "preventing new pigmentation".

2.3 Anti-Ageing and Skin Structural Remodelling Mechanisms

Ellagic acid's anti-ageing effects stem not only from its antioxidant properties but also from direct influence on dermal matrix metabolism:

• Promoting collagen synthesis: In vitro studies demonstrate that ellagic acid stimulates skin fibroblasts to synthesise type I collagen, a key protein for skin structural support and elasticity. Promoting collagen regeneration, it helps improve skin elasticity and plumpness while reducing fine lines.
• Inhibition of Matrix Metalloproteinases: MMPs, particularly MMP-1 (collagenase), are primary enzymes degrading collagen and elastin. Ultraviolet radiation induces MMP-1 expression. Research indicates ellagic acid effectively suppresses MMP-1 activity or expression, thereby protecting existing dermal matrix structures from degradation and delaying photoaging processes.
• Anti-inflammatory and photoprotective effects: Chronic low-grade inflammation is a key driver of skin ageing. Ellagic acid's anti-inflammatory properties suppress the release of inflammatory mediators (such as NF-κB pathway-associated factors), mitigating inflammatory ageing. Concurrently, its antioxidant capacity forms part of the endogenous photoprotective system, reducing both direct and indirect UV damage to skin cells.

In summary, ellagic acid from pomegranate extract delivers multidimensional protection and repair through an integrated network of actions encompassing antioxidant defence, anti-inflammatory effects, pigment regulation, and matrix preservation. Its mechanism of action is well-defined, with clear targets and robust scientific evidence, establishing it as a high-value active ingredient with a clearly understood efficacy mechanism within cosmetic formulations.

3.1 Core Market Applications

Pomegranate extract ellagic acid, with its multi-functional properties, has found precise applications across several high-end cosmetic segments:

Anti-ageing and Skin Repair Series:

• Products Applications: Premium anti-wrinkle serums, repair night creams, anti-ageing ampoules, neck firming treatments.
• Market Positioning: As a core antioxidant within "scientific anti-ageing" formulations, it is frequently combined with peptides, retinol, and vitamin C to create synergistic anti-ageing matrices. For instance, pomegranate extract is now considered in anti-ageing cream formulation development.

Brightening & Spot-Reducing Series:

• Product Applications: Brightening Serums, Spot-Reducing Pens, Radiance Masks, Brightening Creams. In Japan, "pharmaceutical-grade brightening" products (quasi-drugs) containing ellagic acid have established market applications for treating melasma.
• Market Positioning: Positioned as a "highly effective yet gentle" whitening agent. Compared to traditional potent whitening agents, ellagic acid exhibits lower irritation potential, making it suitable for a broader range of skin types, particularly the sensitive skin whitening market. Research has developed creams containing pomegranate peel extract as whitening products.

Sun Protection and After-Sun Repair Series:

• Product Applications: Antioxidant sunscreen lotion, after-sun repair gel, UV barrier cream.
• Market Positioning: Serves as an "endogenous photoprotection" ingredient, elevating the protective level of sunscreen products while addressing indirect light damage not covered by conventional sunscreens. Sensitive Skin & Soothing Repair Series: Application Products: Sensitive Skin Serum, Soothing Cream, Repair Mask.

3.2 Product Formulations and Application Methods

The application of ellagic acid in cosmetic formulations requires overcoming challenges such as its inherent poor water solubility and stability:

• Standard Powder Form:

Characteristics: The most common raw material form, offering high purity (e.g., 40%, 98%) and relatively controllable costs.

Formulation Challenges: Extremely low solubility in water, making direct dispersion in aqueous phases difficult.

Solutions: Typically requires prior dissolution in a small amount of alkaline solution (pH adjustment), propylene glycol, butylene glycol, or ethanol before incorporation into formulations. Suitable for serums, creams, and similar formulations, though pH levels and final stability must be carefully managed.

• Water-soluble ellagic acid formulations:

Characteristics: Prepared via encapsulation (e.g., cyclodextrin), salt formation, or molecular modification, significantly enhancing water solubility (e.g., solubility ≥3% or 7%), facilitating easier application.

Advantages: Easily incorporated into aqueous formulations like toners, serums, and gel masks, representing a key market development focus. For instance, proprietary product EllaWhite® positions water-soluble ellagic acid as its key selling point.

Formulation Recommendations: Directly soluble in aqueous phases; heating to 40-60°C accelerates dissolution. Recommended addition levels range from 0.1% to 2%, adjusted according to product efficacy claims.

3.3 Market Application Cases

Cosmetics containing ellagic acid derivatives are currently highly popular skincare products on the international market. They represent a new frontier developed in recent years by China's pharmaceutical and health products industry, having already become a focal point in beauty and wellness abroad. Numerous domestic and international cosmetics enterprises have skilfully incorporated effective ingredients such as ellagic acid into their formulations while actively pursuing patent protection. By incorporating ellagic acid and tocopheryl acetate into L'Oréal's Source White Essence Photon Bottle, tyrosinase activity is effectively inhibited, thereby suppressing melanin production to achieve the removal of age spots and sunspots.

As a natural active ingredient, ellagic acid presents multiple stability challenges in practical cosmetic formulation development and application, requiring formulators to fully comprehend and appropriately address these issues.

4.1 Photostability Challenges

Ellagic acid exhibits photosensitivity, particularly under ultraviolet (UV) irradiation, where degradation may occur, leading to reduced activity and formulation colour changes.

• Mechanism: The polyphenolic structure of ellagic acid readily undergoes oxidation, polymerisation, or isomerisation upon UV excitation.
• Research Data: Studies indicate that UV exposure adversely affects the stability of aqueous ellagic acid solutions. Specific half-life data varies by formulation, but the design must explicitly incorporate light-shielding principles.
• Solutions: Packaging: Finished products must be housed in opaque or dark-coloured (e.g., amber) glass bottles, aluminium tubes, or plastic containers with light-blocking coatings on inner surfaces. Formulation: Incorporate UV absorbers (e.g., ethylhexyl methoxycinnamate) or utilise light-protective excipients (e.g., cyclodextrin encapsulation). Production and Storage: Raw materials and intermediates must undergo light-protected handling during manufacturing.

4.2 Thermal Stability Concerns

Elevated temperatures accelerate ellagic acid degradation, compromising its stability during manufacturing and long-term storage.

• Research Data: Ellagic acid remains stable for at least four months between 4°C and 30°C, though specific degradation rates require formulation-specific testing. Studies under accelerated conditions at 45°C observed significant ellagic acid depletion.
• Process Restrictions: Prolonged high-temperature sterilisation exceeding 80°C must be avoided. For emulsification, add tannic acid solution during the cooling phase (below 60°C).
• Solutions: Employ low-temperature sterilisation techniques (e.g., membrane filtration) and optimise production workflows. Incorporating stabilisers (e.g., glycerol, certain polysaccharides) into formulations may enhance thermal stability.

4.3 pH Sensitivity

The solubility, chemical form, and stability of ellagic acid are significantly influenced by pH.

• Solubility: Ellagic acid exhibits low solubility under acidic conditions. Solubility increases with rising pH, but stability decreases accordingly.
• Stability: Studies clearly indicate that ellagic acid and its glycosides are more stable at acidic pH levels (e.g., pH 3.5–4.5). Under alkaline conditions (pH >8), ellagic acid glycosides may undergo hydrolysis, and ellagic acid itself becomes unstable with accelerated degradation rates. One study demonstrated that at pH 10, the half-life of a specific ellagic acid glycoside was less than 10 minutes.
• Formulation recommendations: The optimal pH range for formulations is recommended between 3.5 and 5.5. Within this range, relative stability of the ingredients is maintained while meeting the skin-mildness requirements of most cosmetic formulations. Should formulations at higher pH be required, thorough stability challenge testing must be conducted.

As a specialised supplier of plant-derived raw materials, APPCHEM is dedicated to providing the global cosmetics industry with high-quality, highly stable pomegranate extract ellagic acid ingredients. The following are key elements underpinning our core competitiveness:

5.1 Development History and Industry Expertise

Since its inception, APPCHEM has consistently focused on the research, development, and production of natural plant-derived active ingredients. Over two decades of development, we have evolved from a single-product raw material trader into a comprehensive high-tech enterprise integrating cultivation, R&D, manufacturing, and sales. With deep roots in the plant extraction sector and over 20 years of export experience, our products reach major markets including Europe, America, Japan, and South Korea. This has fostered a profound understanding of international cosmetic ingredient regulations and market trends.

[To learn more about our journey, please click here to visit our "Development History" page]

5.2 Research, Innovation and Technological Leadership

Research and development serve as our core driving force. APPCHEM has assembled a multidisciplinary, high-calibre R&D team comprising over ten specialists, including two PhDs and six Master's. We maintain long-term collaborative relationships with several renowned universities and research institutions. The R&D centre is equipped with advanced extraction, separation, purification, and testing apparatus, including High-Performance Liquid Chromatography (HPLC), Gas Chromatography (GC), and UV Spectrophotometers, ensuring quality control throughout the entire process from raw material screening to finished product release. We continuously pursue process innovation, such as developing water-soluble ellagic acid technology to address formulation challenges for our clients.

[To explore our innovation capabilities, please click here to visit our 'R&D and Innovation' page]

5.3 Production Facilities and Quality Control

The company's production base is designed and constructed in strict compliance with GMP standards, featuring clean production workshops spanning approximately 5,000 to 10,000 square metres. The production process encompasses the entire chain from raw material pre-treatment, extraction, concentration, and purification to drying and packaging. It is equipped with modern production facilities, including supercritical CO₂ extraction, membrane separation, and microwave drying, ensuring product yield and purity. Quality management is integrated throughout, underpinned by a comprehensive ISO 9001 Quality Management System and multiple international certifications, including ISO, GMP, HACCP, Kosher, and Halal. Each batch is accompanied by a detailed Certificate of Analysis (COA), with testing metrics comprehensively covering content, purity, impurities, microbiological parameters, heavy metals, and more, ensuring compliance with the highest standards for cosmetic ingredients.

[To view our full certification portfolio, click here to visit our 'Certification' page]

5.4 Service Framework and Ongoing Support

We deliver not merely raw materials, but comprehensive solutions. Our specialised technical services team provides formulation recommendations, stability testing support, and regulatory consultation. Committed to becoming trusted long-term strategic partners, we collaborate to advance innovation and development within the cosmetics industry. Visit our official website to explore further company details, product catalogues, and certification documentation.

Reference

[1]XIE Z K, CHEN F, LI P, et al. Tracking the gastrointestinal fate and prebiotic effect of ellagic acid-rich fruit byproducts: a comprehensive evaluation[J]. Food Chemistry, 2025, 484: 144290. DOI:10.1016/j.foodchem.2025.144290.

[2]LI F P, LUO J X, XIE Q Z, et al. Differential effects of ellagic acid on non-alcoholic fatty liver disease in mice: grouped by urolithin A-producing capacity[J]. Food & Function, 2025, 16: 3166-3179. DOI: 10.1039/d5fo00440c.

[3]FU H J, LI W X, CHENG Q M, et al. Ellagic acid alleviates iron overload-induced liver damage by mitigating ferroptosis through modulation of the TGFβ/Smad signalling pathway[J]. Food Research International, 2025, 214: 116590. DOI: 10.1016/j.foodres.2025.116590.

[4]NAIDU P, DAS M, HANSDA S, et al. Mechanisms of Ellagic Acid (EA)-Mediated Osteogenic Differentiation of Human Dental Pulp-Derived Stem Cells[J]. ACS Omega, 2025, 10(15): 15229-15242. DOI: 10.1021/acsomega.4c10642.